pmid,title,journal,year,drug,disease
40575645,COVID-19 management in patients with comorbid conditions.,World journal of virology,2025,Ruxolitinib,Chronic Obstructive Pulmonary Disease
39268974,"Presence of triple positive driver mutations in JAK2, CALR and MPL in primary myelofibrosis: a case report and literature review.","Hematology (Amsterdam, Netherlands)",2024,Ruxolitinib,Chronic Obstructive Pulmonary Disease
38817459,Vitiligo and Prostate Cancer Correlation.,Cureus,2024,Ruxolitinib,Chronic Obstructive Pulmonary Disease
36059986,Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability.,Frontiers in pharmacology,2022,Ruxolitinib,Chronic Obstructive Pulmonary Disease
35876719,Impact of JAK/STAT inhibitors on human monocyte-derived-macrophages stimulated by cigarette smoke extract and lipopolysaccharide.,Clinical and experimental pharmacology & physiology,2022,Ruxolitinib,Chronic Obstructive Pulmonary Disease
33509955,Phospholipase A2 receptor 1 promotes lung cell senescence and emphysema in obstructive lung disease.,The European respiratory journal,2021,Ruxolitinib,Chronic Obstructive Pulmonary Disease
30224514,IL-17A Attenuates IFN-lambda Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium.,"Journal of immunology (Baltimore, Md. : 1950)",2018,Ruxolitinib,Chronic Obstructive Pulmonary Disease
29508628,Drug-associated pulmonary arterial hypertension.,"Clinical toxicology (Philadelphia, Pa.)",2018,Ruxolitinib,Chronic Obstructive Pulmonary Disease
